 Journal du Net |
Economie > Brevets : les laboratoires au bord du précipice
Journal du Net En 2009, le laboratoire Cephalon (racheté depuis par Teva) a ainsi lancé le Nuvigil, une version "améliorée" du Provigil, dont le brevet expire en mars 2012 aux Etats-Unis. Celui du Nuvigil expire lui en… 2023. Les labos se résolvent aussi parfois à … |
|
Are Mind-Enhancing Drugs a Good Idea?
Smithsonian (blog) In the recent study the drug was Modafinil, designed originally to treat narcolepsy, but in this case given to a group of sleep-deprived surgeons. While the medication didn't seem to improve the performance of the doctors in simulated surgery, … |
|
The Ethics of Designer Brains
Big Think And Modafinil – originally prescribed for narcolepsy – is now being advertised as a way to “cut through the fog of ES (Excessive Sleepiness).” * Grappling with thorny ethical issues is Dr. Paul Rool Wolpe's job. At NASA, he formulates policy on … |
|
Nigeria: How Safe Are Smart Drugs?
AllAfrica.com There are various types of smart drugs ranging from Hydergine – a "smart drug" that dilates the blood vessels of the brain, Piracetam ,Aniracetam ,Minaprine,Oxiracetam, Pramiracetam but Modafinil is one of the new neuro-enhancing smart drugs now being … and more » |